United maintain positive outlook

United Drug has revealed today in its interim management statement (IMS) that during the first quarter of 2008, the group continued to experience good trading conditions in each of its four business divisions and overall group performance is well ahead of the corresponding period in the prior year, in line with expectations.

During the period under review, the group continued its expansion as an international healthcare services company with bolt-on acquisitions in the UK and US markets.